Lipidemia

Metabolic·MeSH: Hyperlipidemias

30 drugs in development·17 companies·2 clinical trials

Drug Pipeline by Phase

Approved(7)

Drug	Company
colesevelam	Impax Laboratories, LLC (IPXL)
fenofibrate	Amneal Pharmaceuticals, Inc. (AMRX)
fenofibrate	ANI PHARMACEUTICALS INC (ANIP)
nexletol	Esperion Therapeutics, Inc. (ESPR)
nexlizet	Esperion Therapeutics, Inc. (ESPR)
pitavastatin	Mylan II B.V. (MYL)
TriCor™	ABBOTT LABORATORIES (ABT)

Phase 3(10)

Drug	Company
Enlicitide	Merck & Co., Inc. (MRK)
monotherapy ezetimibe	NEWAMSTERDAM PHARMA CO N.V. (NAMS)
monotherapy obicetrapib	NEWAMSTERDAM PHARMA CO N.V. (NAMS)
obicetrapib	NEWAMSTERDAM PHARMA CO N.V. (NAMS)
obicetrapib + ezetimibe	NEWAMSTERDAM PHARMA CO N.V. (NAMS)
obicetrapib + ezetimibe fdc	NEWAMSTERDAM PHARMA CO N.V. (NAMS)
obicetrapib 10 mg + ezetimibe 10 mg fdc daily	NEWAMSTERDAM PHARMA CO N.V. (NAMS)
obicetrapib 10 mg + obicetrapib/evolocumab 140 mg q 2 weeks	NEWAMSTERDAM PHARMA CO N.V. (NAMS)
Rosuvastatin	Merck & Co., Inc. (MRK)
syh2053	NYMOX PHARMACEUTICAL CORP (NYMXF)

Phase 2(1)

Drug	Company
sln312	Silence Therapeutics Plc (SLN)

Phase 1(4)

Drug	Company
aln-apoc3	REGENERON PHARMACEUTICALS, INC. (REGN)
ARO-ANG3	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARO-APOC3	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ly3885125	ELI LILLY & Co (LLY)

Preclinical(2)

Drug	Company
cdx-101	CARDAX, INC. (CDXI)
DGAT-1 inhibitors	Viking Therapeutics, Inc. (VKTX)

Unknown(2)

Drug	Company
gemcabene	MetaVia Inc. (MTVA)
Lipanthyl™	ABBOTT LABORATORIES (ABT)

N/A(1)

Drug	Company
Niacin	Cidara Therapeutics, Inc. (CDTX)

Phase 1/Phase 2(2)

Drug	Company
ARO-DIMER-PA	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
ARO-DIMERPA	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Phase 4(1)

Drug	Company
yangxin dawayimixike honey paste	NYMOX PHARMACEUTICAL CORP (NYMXF)

BioSniper tracks 30 drugs in development for Lipidemia across 17 companies.

There are 2 clinical trials targeting Lipidemia tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.